S&P 500Bucket avgCompareDividend-adjusted total return · S&P 500 uses VOO · Aug 18, 2026 – Nov 16, 2026
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.2% | −3.6% | +1.2% | −10.7% | +7.0% | +12.4% | +74.9% | +14.0% | +25.0% |
| Peer average | −1.2% | −2.1% | +1.3% | −5.3% | +14.8% | +18.8% | +63.0% | +27.5% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$20 of every $1,000 in MMSC is Xometry,
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | XMTRXometry, () | Industrials | 2.02% | $201.90 | 8,628 | $1.0M |
| 2 | FROGJFrog | Technology | 1.91% | $190.89 | 8,589 | $976K |
| 3 | —US Dollar | — | 1.83% | $183.15 | 936K | $936K |
| 4 | ZETAZETA Global () | Technology | 1.75% | $174.55 | 24K | $892K |
| 5 | OLLIOllie's Bargain Outlet | Consumer Defensive | 1.51% | $150.67 | 8,127 | $770K |
| 6 | NTSKNetskope, () | Technology | 1.39% | $139.24 | 33K | $712K |
| 7 | VRNSVaronis Systems | Technology | 1.33% | $133.27 | 14K | $681K |
| 8 | SAILSailPoint | Technology | 1.31% | $130.70 | 32K | $668K |
| 9 | TVTXTravere Therapeutics | Healthcare | 1.30% | $129.72 | 13K | $663K |
| 10 | GHGuardant Health | Healthcare | 1.25% | $125.01 | 4,212 | $639K |
| 11 | SYRESpyre Therapeutics | Healthcare | 1.24% | $124.01 | 6,095 | $634K |
| 12 | PTGXProtagonist Therapeutics | Healthcare | 1.12% | $112.42 | 4,388 | $575K |
| 13 | RGENRepligen | Healthcare | 1.06% | $105.74 | 3,221 | $540K |
| 14 | LGNDLigand Pharmaceuticals () | Healthcare | 1.03% | $102.94 | 1,704 | $526K |
| 15 | PRAXPraxis Precision Medicines | Healthcare | 0.99% | $99.44 | 1,549 | $508K |
of the $584B in 112 Small cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | XMTR | Xometry, () | 2.02% |
| 2 | FROG | JFrog | 1.91% |
| 3 | ZETA | ZETA Global () | 1.75% |
| 4 | OLLI | Ollie's Bargain Outlet | 1.51% |
| 5 | NTSK | Netskope, () | 1.39% |
| 6 | VRNS | Varonis Systems | 1.33% |
| 7 | SAIL | SailPoint | 1.31% |
| 8 | TVTX | Travere Therapeutics | 1.30% |
| 9 | GH | Guardant Health | 1.25% |
| 10 | SYRE | Spyre Therapeutics | 1.24% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 13, 2024 | Dec 31, 2024 | $0.0854 |